Bausch Health Companies BHC
NYSE BHC
$5.80 +0.08 (+1.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Selling, General & Administrative (2009 - 2026)

Updated

Bausch Health Companies' Selling, General & Administrative was $907 million in Q2 2026, up 1.5% from $894 million a year earlier and up 5.3% from the prior quarter.

Analysis

Bausch Health Companies (BHC) Selling, General & Administrative (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Bausch Health Companies' Selling, General & Administrative was $3.45 billion through Jun 30, 2026, up 0.4% year-over-year; for FY2025, it came in at $3.44 billion, up 4.3% from FY2024.

  • Selling, General & Administrative has now increased for three consecutive years, with a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $3.3 billion in FY2024 (+13.0%), $2.92 billion in FY2023 (+11.1%), $2.63 billion in FY2022 (unchanged) and $2.62 billion in FY2021 (+10.9%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2009.
  • Compared with a year earlier, Selling, General & Administrative was higher in six of the last eight quarters, with growth averaging 5.6%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2024 (growth of 18.9%); the worst was Q3 2025 (a decline of 6.5%).
  • Per Business Quant data, BHC's Selling, General & Administrative in the three quarters before Q2 2026 was $861 million (Q1 2026), $882 million (Q4 2025) and $795 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Bausch Health Companies 2.17 Bn -2.60 Bn 2.08 Bn 907.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 907.00 Mn
Mar 31, 2026 861.00 Mn
Dec 31, 2025 882.00 Mn
Sep 30, 2025 795.00 Mn
Jun 30, 2025 894.00 Mn
Mar 31, 2025 867.00 Mn
Dec 31, 2024 820.00 Mn
Sep 30, 2024 850.00 Mn
Jun 30, 2024 832.00 Mn
Mar 31, 2024 794.00 Mn
Dec 31, 2023 766.00 Mn
Sep 30, 2023 715.00 Mn
Jun 30, 2023 711.00 Mn
Mar 31, 2023 725.00 Mn
Dec 31, 2022 666.00 Mn
Sep 30, 2022 661.00 Mn
Jun 30, 2022 676.00 Mn
Mar 31, 2022 622.00 Mn
Dec 31, 2021 680.00 Mn
Sep 30, 2021 653.00 Mn
API Access

Bausch Health Companies Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BHC&period=max&api_key=YOUR_API_KEY